Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
The ambiguous role of FPR1 in immunity and inflammation — Erika Vacchelli (2020) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
The ambiguous role of FPR1 in immunity and inflammation
Shared by
Guido Guido Kroemer
The ambiguous role of FPR1 in immunity and inflammation
Article
2020
en
Authors
EV
Erika Vacchelli
JN
Julie Le Naour
Guido Guido Kroemer
Abstract
1 min read
Formyl peptide receptors (FPRs) are pattern recognition receptors (PPRs) that are involved in multiple pathological processes. These G protein-coupled receptors expressed by immune cells transduce ...
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2016
Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1
Erika Vacchelli
,
Yuting Ma
,
Elisa Elena Baracco
,
Laurence Zitvogel
,
Guido Guido Kroemer
Article
2020
No impact of cancer and plague-relevant <i>FPR1</i> polymorphisms on COVID-19
Adriana Petrazzuolo
,
Julie Le Naour
,
Erika Vacchelli
,
Pascale Gaussem
,
Syrine Ellouze
,
Georges Jourdi
,
Éric Solary
,
Michaëla Fontenay
,
David M. Smadja
,
Guido Guido Kroemer
Article
2016
Impact of Pattern Recognition Receptors on the Prognosis of Breast Cancer Patients Undergoing Adjuvant Chemotherapy
Erika Vacchelli
,
David Enot
,
Federico Pietrocola
,
Laurence Zitvogel
,
Guido Guido Kroemer
Article
2023
Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis
Julie Le Naour
,
Léa Montégut
,
Yuhong Pan
,
Sarah Adriana Scuderi
,
Pierre Cordier
,
Adrien Joseph
,
Allan Sauvat
,
Valerio Iebba
,
Juliette Paillet
,
Gladys Ferrere
,
Ludivine Bréchard
,
Claire Mulot
,
Grégory Dubourg
,
Laurence Zitvogel
,
Jonathan Pol
,
Erika Vacchelli
,
Pierre Laurent‐Puig
,
Guido Guido Kroemer
Article
2006
Pathogen Recognition and Innate Immunity
Akira Shizuo
,
Satoshi Uematsu
,
Osamu Takeuchi
Cell
Discussion(0)
No comments yet. Be the first to comment.